Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.38 USD | +0.96% | -10.12% | +158.88% |
05-09 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
04-29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+158.88% | 1.14B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+49.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : SVB Leerink Adjusts Price Target on Cullinan Management to $54 From $48, Maintains Outperform Rating